newsfilter
← Latest News
GlobeNewswire·

Relay Therapeutics to Participate in Two Upcoming Investor Conferences in September

  • Relay Therapeutics (NASDAQ: RLAY) announced management will participate in two September 2026 fireside chats.
  • The first event is the 2026 Wells Fargo Healthcare Conference on Tuesday, September 8, 2026, at 1:30 p.m. ET.
  • The second event is the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, September 16, 2026, at 9:15 a.m. ET.
  • Both webcasts will be live-streamed via Relay Therapeutics' investor relations website, with archived replays available for up to 30 days.
  • Relay Therapeutics utilizes its Dynamo platform to develop small molecule therapies for intractable protein targets in cancer & genetic diseases.
  • Lead asset zovegalisib, a pan-mutant selective PI3Kα inhibitor, is currently in a Phase 3 trial (ReDiscover-2) for HR+/HER2- metastatic breast cancer.
  • Zovegalisib is also being studied for PI3Kα-driven vascular anomalies, while the pipeline includes programs for NRAS-driven solid tumors & Fabry disease.